Bionoid Pharma Inc
OTC:BINP
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
GP Petroleums Ltd
NSE:GULFPETRO
|
IN |
|
Lamda Development SA
LSE:0NCY
|
GR |
|
Similarweb Ltd
NYSE:SMWB
|
IL |
|
Skycity Entertainment Group Ltd
NZX:SKC
|
NZ |
|
Formycon AG
XETRA:FYB
|
DE |
|
China Southern Power Grid Energy Efficiency&Clean Energy Co Ltd
SZSE:003035
|
CN |
|
Wuhu Token Sciences Co Ltd
SZSE:300088
|
CN |
|
Edel SE & Co KgaA
XETRA:EDL
|
DE |
|
Betterware de Mexico SAPI de CV
NYSE:BWMX
|
MX |
|
Waskita Karya (Persero) Tbk PT
IDX:WSKT
|
ID |
Bionoid Pharma Inc
Long-Term Debt
Bionoid Pharma Inc
Long-Term Debt Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Long-Term Debt | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
B
|
Bionoid Pharma Inc
OTC:BINP
|
Long-Term Debt
$0
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Boston Scientific Corp
NYSE:BSX
|
Long-Term Debt
$11.1B
|
CAGR 3-Years
8%
|
CAGR 5-Years
4%
|
CAGR 10-Years
7%
|
|
|
Edwards Lifesciences Corp
NYSE:EW
|
Long-Term Debt
$598.3m
|
CAGR 3-Years
0%
|
CAGR 5-Years
0%
|
CAGR 10-Years
0%
|
|
|
Stryker Corp
NYSE:SYK
|
Long-Term Debt
$14.9B
|
CAGR 3-Years
8%
|
CAGR 5-Years
2%
|
CAGR 10-Years
16%
|
|
|
Abbott Laboratories
NYSE:ABT
|
Long-Term Debt
$9.9B
|
CAGR 3-Years
-12%
|
CAGR 5-Years
-11%
|
CAGR 10-Years
5%
|
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Long-Term Debt
$0
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Bionoid Pharma Inc
Glance View
Bionoid Pharma, Inc. operates as a medical device company. The company is headquartered in Huntington Beach, California. The company went IPO on 2007-06-25. The firm develops and markets medical devices and technologies for the orthopedic and pain management markets. The firm develops and commercializes a platform called muscle pattern recognition (MPR), a clinical tool for the analysis of muscle function in patients presenting with back pain. MPR provides information regarding muscle recruitment patterns in patients suffering from neck and back pain that can assist healthcare professionals in the evaluation and treatment of neck and back injuries and illnesses. The Company, through BIOflex Medical Magnetics, Inc., develops and sells magnetic therapy devices. The firm sells its products through several channels, including Web-based sales; corporate partnerships; direct response television (DRTV); retail distribution; Internet catalogs, and through a network of distributors across the world.
See Also
What is Bionoid Pharma Inc's Long-Term Debt?
Long-Term Debt
0
USD
Based on the financial report for Dec 31, 2011, Bionoid Pharma Inc's Long-Term Debt amounts to 0 USD.
